Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Returning genetic research results to individuals: points-to-consider.
Renegar G, Webster CJ, Stuerzebecher S, Harty L, Ide SE, Balkite B, Rogalski-Salter TA, Cohen N, Spear BB, Barnes DM, Brazell C. Renegar G, et al. Among authors: spear bb. Bioethics. 2006 Feb;20(1):24-36. doi: 10.1111/j.1467-8519.2006.00473.x. Bioethics. 2006. PMID: 16680905 Review.
Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group.
Anderson DC, Gomez-Mancilla B, Spear BB, Barnes DM, Cheeseman K, Shaw PM, Friedman J, McCarthy A, Brazell C, Ray SC, McHale D, Hashimoto L, Sandbrink R, Watson ML, Salerno RA, Cohen N, Lister CE; Pharmacogenetics Working Group. Anderson DC, et al. Among authors: spear bb. Pharmacogenomics J. 2002;2(5):284-92. doi: 10.1038/sj.tpj.6500131. Pharmacogenomics J. 2002. PMID: 12439734 Review. No abstract available.
Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop.
Lesko LJ, Salerno RA, Spear BB, Anderson DC, Anderson T, Brazell C, Collins J, Dorner A, Essayan D, Gomez-Mancilla B, Hackett J, Huang SM, Ide S, Killinger J, Leighton J, Mansfield E, Meyer R, Ryan SG, Schmith V, Shaw P, Sistare F, Watson M, Worobec A. Lesko LJ, et al. Among authors: spear bb. J Clin Pharmacol. 2003 Apr;43(4):342-58. doi: 10.1177/0091270003252244. J Clin Pharmacol. 2003. PMID: 12723455
Pharmacogenomic data submissions to the FDA: clinical case studies.
Trepicchio WL, Williams GA, Essayan D, Hall ST, Harty LC, Shaw PM, Spear BB, Wang SJ, Watson ML. Trepicchio WL, et al. Among authors: spear bb. Pharmacogenomics. 2004 Jul;5(5):519-24. doi: 10.1517/14622416.5.5.519. Pharmacogenomics. 2004. PMID: 15212589 No abstract available.
Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group.
Patterson SD, Cohen N, Karnoub M, Truter SL, Emison E, Khambata-Ford S, Spear B, Ibia E, Sproule R, Barnes D, Bhathena A, Bristow MR, Russell C, Wang D, Warner A, Westelinck A, Brian W, Snapir A, Franc MA, Wong P, Shaw PM. Patterson SD, et al. Pharmacogenomics. 2011 Jul;12(7):939-51. doi: 10.2217/pgs.11.52. Pharmacogenomics. 2011. PMID: 21787188
Pharmacogenetics: improving drug and dose selection.
Bhathena A, Spear BB. Bhathena A, et al. Among authors: spear bb. Curr Opin Pharmacol. 2008 Oct;8(5):639-46. doi: 10.1016/j.coph.2008.07.013. Epub 2008 Sep 26. Curr Opin Pharmacol. 2008. PMID: 18762278 Review.
39 results